A detailed history of Versant Capital Management, Inc transactions in Alphatec Holdings, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 49 shares of ATEC stock, worth $427. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49
Previous 154 68.18%
Holding current value
$427
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$5.45 - $11.87 $572 - $1,246
-105 Reduced 68.18%
49 $0
Q2 2024

Jul 05, 2024

BUY
$9.49 - $14.26 $1,461 - $2,196
154 New
154 $1,000
Q1 2020

Apr 17, 2020

SELL
$2.26 - $7.47 $16,864 - $55,741
-7,462 Closed
0 $0
Q1 2019

Apr 23, 2019

BUY
$1.19 - $2.92 $8,857 - $21,733
7,443 Added 39173.68%
7,462 $19,000
Q1 2019

Apr 23, 2019

SELL
$1.19 - $2.92 $8,857 - $21,733
-7,443 Reduced 99.75%
19 $19,000
Q3 2018

Oct 15, 2018

BUY
$2.69 - $3.89 $20,072 - $29,027
7,462 New
7,462 $25,000

Others Institutions Holding ATEC

About Alphatec Holdings, Inc.


  • Ticker ATEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 104,656,000
  • Market Cap $914M
  • Description
  • Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...
More about ATEC
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.